Business Description
Carl Zeiss Meditec AG
ISIN : DE0005313704
Compare
Compare
Traded in other countries / regions
AFX.Germany0DHC.UKCZMWY.USA1AFX.ItalyAFX.AustriaAFX.SwitzerlandAFX.Mexico IPO Date
2021-08-17Description
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.07 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | 0.38 | |||||
| Interest Coverage | 19.41 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 8.42 | |||||
| Beneish M-Score | -2.14 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.1 | |||||
| 3-Year EBITDA Growth Rate | 23.4 | |||||
| 3-Year EPS without NRI Growth Rate | 33.4 | |||||
| 3-Year FCF Growth Rate | 0.9 | |||||
| 3-Year Book Growth Rate | 14.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 9.02 | |||||
| Future 3-5Y Total Revenue Growth Rate | 9.62 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | |||||
| Quick Ratio | 2.48 | |||||
| Cash Ratio | 0.02 | |||||
| Days Inventory | 183.14 | |||||
| Days Sales Outstanding | 45.46 | |||||
| Days Payable | 84.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 19.2 | |||||
| Shareholder Yield % | 0.45 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 57.35 | |||||
| Operating Margin % | 15.82 | |||||
| Net Margin % | 13.22 | |||||
| FCF Margin % | 1.52 | |||||
| ROE % | 13.53 | |||||
| ROA % | 9.67 | |||||
| ROIC % | 9.04 | |||||
| ROC (Joel Greenblatt) % | 72.71 | |||||
| ROCE % | 17.64 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 31.52 | |||||
| Forward PE Ratio | 32.36 | |||||
| PE Ratio without NRI | 31.52 | |||||
| Shiller PE Ratio | 46.94 | |||||
| PEG Ratio | 1.61 | |||||
| PS Ratio | 4.17 | |||||
| PB Ratio | 4.05 | |||||
| Price-to-Tangible-Book | 5.89 | |||||
| Price-to-Free-Cash-Flow | 287.35 | |||||
| Price-to-Operating-Cash-Flow | 287.35 | |||||
| EV-to-EBIT | 22.18 | |||||
| EV-to-Forward-EBIT | 29.77 | |||||
| EV-to-EBITDA | 22.18 | |||||
| EV-to-Forward-EBITDA | 26.3 | |||||
| EV-to-Revenue | 4.35 | |||||
| EV-to-Forward-Revenue | 6.52 | |||||
| EV-to-FCF | 290.33 | |||||
| Price-to-Projected-FCF | 3.09 | |||||
| Price-to-DCF (Earnings Based) | 2.27 | |||||
| Price-to-DCF (FCF Based) | 35.91 | |||||
| Price-to-Median-PS-Value | 0.92 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.53 | |||||
| Price-to-Graham-Number | 2.81 | |||||
| Price-to-Net-Current-Asset-Value | 8.42 | |||||
| Earnings Yield (Greenblatt) % | 4.51 | |||||
| FCF Yield % | 0.35 | |||||
| Forward Rate of Return (Yacktman) % | 22.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Carl Zeiss Meditec AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 39,535.844 | ||
| EPS (TTM) (MXN) | 58.431 | ||
| Beta | 0 | ||
| Volatility % | 0.61 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (MXN) | 0 | ||
| 20-Day SMA (MXN) | 3258.2 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (MXN) | 3258.2 - 3258.2 | ||
| Shares Outstanding (Mil) | 89.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Carl Zeiss Meditec AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Carl Zeiss Meditec AG Stock Events
| Event | Date | Price(MXN) | ||
|---|---|---|---|---|
| No Event Data | ||||
Carl Zeiss Meditec AG Frequently Asked Questions
What is Carl Zeiss Meditec AG(MEX:AFX)'s stock price today?
The current price of MEX:AFX is MXN3258.20. The 52 week high of MEX:AFX is MXN3258.20 and 52 week low is MXN3258.20.
When is next earnings date of Carl Zeiss Meditec AG(MEX:AFX)?
The next earnings date of Carl Zeiss Meditec AG(MEX:AFX) is 2024-05-08.
Does Carl Zeiss Meditec AG(MEX:AFX) pay dividends? If so, how much?
Carl Zeiss Meditec AG(MEX:AFX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers